The Avicenna Alliance has been given the green light by the European Commission to pursue the creation of a Public Private Partnership (PPP) on in silico medicine.
The Avicenna Alliance is currently engaged in outreach with a multitude of organisations with an interest in in silico technologies to pursue the creation of a PPP. The development of a PPP is the primary activity of the Avicenna Alliance for its 1st year and aims to create new funding streams for in silico projects across Europe.
The Alliance will be in continuous contact with the European Commission to ensure the maximum value of this PPP.
For more information on the Avicenna Alliance click here.